Beijing Arion Cancer Center
Beijing's only private Grade III specialist cancer hospital built entirely around real-time, full-course MDT — where every patient has a dedicated Case Manager and a team of oncology specialists who co-own their care from first consultation through to follow-up, supported by a strategic partnership with UPMC (University of Pittsburgh Medical Center).
About Beijing Arion Cancer Center
Beijing Arion Cancer Center (北京美中爱瑞肿瘤医院) is a Grade III tertiary specialist cancer hospital approved by the Beijing Municipal Health Commission in January 2021 and operational since February 2021. Located in Daxing District — approximately 15–20 minutes from Beijing Daxing International Airport (PKX) — the hospital occupies 32,000 square metres and operates 400 dedicated oncology beds, including 60 day-chemotherapy beds and 24 ICU and emergency observation beds. The founding team was drawn from oncology departments at Beijing's top public tertiary hospitals, bringing academic-grade clinical standards into a purpose-built private cancer facility. Investors include Meizhong Yihe Medical Group, Centurium Capital (大钲资本), and Yuanyang Capital.
Arion's core clinical philosophy is real-time, full-course Multidisciplinary Treatment (MDT). Unlike hospitals that convene a one-time multidisciplinary panel before treatment begins, Arion embeds MDT as the continuous operating standard across the entire patient journey. Each patient is assigned a dedicated Case Manager at intake and a core MDT team comprising medical oncologist, surgical oncologist, radiation oncologist, pathologist, and imaging specialist who collectively own the care plan from diagnosis through active treatment, response assessment, and long-term follow-up. The hospital is organised around twelve disease-specific centres: Lung Cancer, Breast Cancer, Gynecologic Oncology, Gastrointestinal Oncology, Hepatobiliary Oncology, Urologic Oncology, Neuro-Oncology, Head and Neck / Thyroid Cancer, Lymphoma, Radiation Oncology, Cancer Rehabilitation, and Precision Health Medicine — each with its own dedicated MDT core team.
Arion holds a formal strategic partnership with UPMC (University of Pittsburgh Medical Center), one of the leading academic medical centres in the United States. Under this collaboration, the two institutions jointly operate an International Advanced MDT Committee for Complex Oncology Cases, which includes over 20 Chinese and American top-tier oncologists and convenes bi-weekly to provide cross-border specialist input on difficult or rare presentations. Hospital President Dr. Xu Zhonghuang — formerly a professor at Peking Union Medical College Hospital (PUMCH) with 29 years of clinical experience — leads the institution. The hospital also holds GCP (Good Clinical Practice) certification, operates a dedicated clinical trials unit with its own GCP inpatient ward, and has been a Beijing medical insurance designated institution since June 2022.
For international patients, Arion provides English-speaking coordinators, a dedicated international patient liaison, and an International MDT Centre that allows a patient's home-country oncologist to join Arion's tumour board review remotely. CancerFax works with Arion to support patients who need a second opinion on a complex diagnosis, access to China-approved immunotherapies or targeted agents, Da Vinci robotic surgery, active clinical trial enrolment, or a combined Chinese-American oncology consultation. Through CancerFax, patients can share their medical records for a preliminary MDT review before committing to travel, and receive coordinated support for medical visa, accommodation, and logistics for their Beijing stay.
| Hospital at a Glance | |
|---|---|
| Country | China |
| City | Beijing — Daxing District |
| Established | 2021 (approved January 2021; opened February 2021) |
| Hospital Type | Grade III Private Specialist Cancer Hospital |
| Accreditation | Beijing Municipal Health Commission · GCP Certified · Beijing Medical Insurance Designated Institution (since June 2022) |
| Beds | 400 total (including 60 day-chemotherapy beds and 24 ICU / emergency observation beds) |
| Annual Patients | ⚠ VERIFY: patient volume not publicly disclosed — confirm with Arion before publishing |
| Research Focus | Immunotherapy · Targeted Therapy · Real-Time MDT Oncology · GCP Clinical Trials · UPMC Joint Research |
Why Patients Choose Beijing Arion Cancer Center
Arion combines Beijing's top public-hospital oncology expertise with a continuous real-time MDT model, a live UPMC strategic partnership, GCP-certified clinical trials, Da Vinci robotic surgery, TrueBeam radiotherapy, and direct proximity to Beijing Daxing International Airport — the only private Grade III cancer hospital in Beijing structured this way.
Cancer Specialties and Clinical Departments
Arion provides comprehensive oncology across twelve disease-specific MDT centres, with particular depth in lung cancer, GI and hepatobiliary oncology, breast and gynecologic cancers, and lymphoma — supported by Da Vinci robotic surgery, TrueBeam radiotherapy, immunotherapy guided by NGS genomic profiling, and GCP-certified clinical trials.
Advanced Treatment Capabilities
Medical Team at Beijing Arion Cancer Center
Arion's medical team was assembled from oncology specialists at Beijing's leading public tertiary hospitals. Hospital President Dr. Xu Zhonghuang — formerly a professor at Peking Union Medical College Hospital (PUMCH) with nearly three decades of clinical oncology practice — leads the institution. Every clinical department operates on the MDT model, with specialists in medical oncology, surgical oncology, radiation oncology, pathology, radiology, and endoscopy working in integrated disease-specific units rather than siloed departments. Each unit maintains a dedicated core MDT team that owns patient care from intake through follow-up.
Arion's International Advanced MDT Committee for Complex Oncology Cases, jointly established with UPMC, includes over 20 top-tier Chinese and American oncologists and convenes bi-weekly. UPMC oncologist Professor Sun Min chairs the committee; Dr. Xu Zhonghuang serves as vice-chair. For international patients with complex or rare presentations, or for those who need their home-country oncologist integrated into the treatment planning process, CancerFax can facilitate a case review request before any travel commitment is made.
Patients seeking specific physician consultations or second opinions may request a review through the CancerFax coordination process before confirming travel or admission. CancerFax will confirm in advance which named consultant will lead the patient's MDT team.
Clinical Infrastructure and Technology
Arion's 32,000 m² Daxing campus integrates twelve disease-specific MDT cancer centres, a GCP-certified clinical trials unit, Da Vinci robotic surgical suite, TrueBeam linear accelerator, PET-CT, MRI, CT, advanced endoscopy, and a comprehensive molecular pathology laboratory — all in a purpose-built specialist cancer facility.
- PET-CT — integrated metabolic and anatomic cancer staging and treatment response assessment
- MRI — high-resolution soft tissue, neurologic, and hepatobiliary tumour imaging
- CT — multi-phase diagnostic, staging, and interventional guidance
- Digital subtraction angiography (DSA) — interventional radiology and hepatic tumour ablation support
- Breast ABUS (automated breast ultrasound) and digital mammography for breast cancer screening and staging
- TrueBeam linear accelerator — precision external beam radiotherapy and SBRT
- Brachytherapy afterloader (後裝機) — HDR brachytherapy for gynaecologic and select solid tumour cases
- Da Vinci robotic surgical system — minimally invasive oncological surgery across multiple tumour types
- Ultrasound endoscopy — GI tumour staging, submucosal lesion assessment, and endoscopic intervention
- Next-generation sequencing (NGS) for comprehensive somatic and germline genomic profiling
- Molecular pathology and immunohistochemistry for biomarker-driven therapy selection
- Tumour marker panels and liquid biopsy for monitoring and early detection
- GCP-certified clinical laboratory supporting active oncology clinical trials to international standards
- 400 specialist inpatient oncology beds across twelve disease-specific MDT centres
- 60-bed day-chemotherapy ward for outpatient infusion and day-treatment programmes
- 24-bed ICU and emergency observation unit for high-acuity oncology patients
- Dedicated GCP clinical trial inpatient ward with independent monitoring and IRB-approved protocols
International Patient Support at Beijing Arion Cancer Center
Arion is located 15–20 minutes from Beijing Daxing International Airport, has English-speaking international patient coordinators on site, accepts self-pay international patients and direct insurance billing, and offers an International MDT Centre that can integrate overseas oncologists into the patient's tumour board remotely. CancerFax manages end-to-end coordination at no cost to the patient.
What to Prepare Before Traveling
- arrow_rightCompile all diagnostic materials — pathology reports, biopsy slides or blocks where available, imaging (DICOM files preferred; CD or USB accepted), surgical records, prior treatment summaries including chemotherapy regimens, and a current medication list. Share these with CancerFax in any language; CancerFax handles translation before forwarding to Arion's MDT team.
- arrow_rightCancerFax screens your case and submits it to Arion's MDT team for a preliminary clinical review. You will receive an initial assessment and proposed treatment outline — including which specialist centre and Case Manager would be assigned — before any travel commitment is required.
- arrow_rightOnce you confirm, CancerFax coordinates your arrival: medical visa invitation letter, airport transfer from Beijing Daxing International Airport (PKX) — approximately 15–20 minutes to the Daxing campus — accommodation, and your first in-person MDT consultation at Arion.
Arion is a Beijing medical insurance designated institution and fully accepts international self-pay patients. CancerFax supports insurance verification, billing coordination, and post-treatment follow-up planning at no cost. Contact: +86 400-898-0939 | www.arioncare.cn
Patient Facilities at Beijing Arion Cancer Center
Arion's purpose-built 32,000 m² Daxing campus includes 400 specialist oncology beds, a 60-bed day-chemotherapy unit, dedicated GCP clinical trial ward, advanced ICU, endoscopy centre, and comprehensive patient support services designed for both domestic and international patients.
Family members accompanying international patients are supported throughout the stay at Arion. The hospital's Case Manager system means families have a named coordinator to contact for any logistical question — appointments, translation, meal planning, billing, or accommodation. CancerFax can also assist with extended-stay planning in Daxing District for longer treatment courses.
How to Reach Beijing Arion Cancer Center
Arion is located in Daxing District, Beijing — approximately 15–20 minutes from Beijing Daxing International Airport (PKX) by taxi, and accessible by metro and public bus from central Beijing.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Beijing Arion Cancer Center — Patient Questions Answered
CancerFax acts as your navigator from wherever you are now to Arion's specialist MDT team in Beijing — handling everything from initial case review to post-treatment follow-up, at no cost to you.
Here is what happens step by step. First, you share your medical documents with CancerFax — pathology reports, imaging (DICOM preferred), surgical records, and treatment history in any language; CancerFax handles translation. Second, CancerFax screens your case and submits it to Arion's MDT team for a preliminary clinical review. You receive an initial assessment and proposed treatment outline — including which specialist centre and Case Manager would be assigned — before any travel is committed. Third, if you decide to proceed, CancerFax coordinates your Beijing arrival: medical visa invitation letter, airport transfer from Daxing International Airport (15–20 minutes to the hospital), and accommodation. Fourth, during your stay CancerFax supports you with interpretation, billing coordination, and communication between you, Arion's team, and your home oncologist if needed. Fifth, after you return home, CancerFax can coordinate remote follow-up consultations with Arion through the International MDT Centre. There is no cost to submit your case and no obligation to travel until you are satisfied with the preliminary assessment.
Most hospitals convene a multidisciplinary review once — when the initial treatment plan is drawn up — after which specialists typically work separately. At Arion, MDT is the continuous operating standard for every patient's entire treatment journey. A core team comprising medical oncologist, surgical oncologist, radiation oncologist, pathologist, and imaging specialist collectively owns each patient's care plan, reconvening every time a significant decision point is reached or the patient's condition changes. A dedicated Case Manager — assigned at intake and present throughout — coordinates all departments and acts as the patient's single point of contact. For patients with complex, rare, or multi-line cancer cases, this model substantially reduces the risk of misalignment between different specialists' decisions.
Yes. Arion's International MDT Centre is specifically designed to connect overseas physicians with the hospital's tumour board. Your home-country oncologist can join Arion's MDT review session remotely, review the proposed treatment plan, and provide input before treatment begins. This cross-border collaboration model was formalised through Arion's strategic partnership with UPMC (University of Pittsburgh Medical Center), which includes a joint International Advanced MDT Committee for Complex Oncology Cases convening bi-weekly with over 20 Chinese and American oncology specialists. CancerFax coordinates the scheduling and logistics of this remote participation.
Arion offers several therapies and agents approved in China that are not yet widely available or accessible in many other countries. These include a broader range of China-approved PD-1/PD-L1 checkpoint inhibitors and combination immunotherapy regimens, China-approved targeted drugs for lung, liver, GI, and other solid tumours, CAR-T cell therapy guided by NGS genomic profiling, and access to GCP-certified active oncology clinical trials. Arion also provides Da Vinci robotic surgery for multiple cancer types and TrueBeam-based precision radiotherapy. All treatment decisions are made through the MDT process and underpinned by comprehensive molecular pathology and NGS tumour profiling.
Arion is approximately 15–20 minutes by taxi from Beijing Daxing International Airport (PKX) — making it the nearest international-standard cancer hospital to Beijing's main international gateway. English-speaking international patient coordinators are available on site, and the hospital accepts self-pay international patients as well as direct billing with select international insurance providers. CancerFax arranges airport transfer, nearby accommodation, on-ground interpretation, and all medical logistics so that the practical aspects of coming to Beijing for cancer care are as straightforward as possible.
Send Your Medical Reports to Beijing Arion Cancer Center via CancerFax
CancerFax reviews your records, assesses whether Arion's MDT model, UPMC-backed tumour board, robotic surgery, or clinical trial access is the right clinical fit for your case, and coordinates your preliminary review or in-person consultation — at no cost and with full medical confidentiality.